top of page

UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims

Writer's picture: Tex PatientsTex Patients

A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs) have taken in large profits on lifesaving medicine for heart disease, cancer and HIV.


Pharmacy Benefit Managers are third-party companies connected to pharmacies that are intermediaries between insurance providers and pharmaceutical manufacturers and claim to reduce consumer costs.


The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands of percent.


By doing so, they collectively added $7.3 billion in revenue, the report states.Figures released with the report show that in 2022, the final year of the study, two cancer drugs had the highest markup.


1 view0 comments

Comments


TCFP_TX_Logo.png
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn

Paid for by the Texas Coalition for Patients

bottom of page